Clarius Group LLC’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $445K | Sell |
1,162
-175
| -13% | -$67K | 0.03% | 276 |
|
2025
Q1 | $462K | Sell |
1,337
-203
| -13% | -$70.1K | 0.03% | 253 |
|
2024
Q4 | $462K | Buy |
1,540
+247
| +19% | +$74.1K | 0.03% | 233 |
|
2024
Q3 | $523K | Sell |
1,293
-33
| -2% | -$13.4K | 0.04% | 213 |
|
2024
Q2 | $426K | Sell |
1,326
-70
| -5% | -$22.5K | 0.03% | 239 |
|
2024
Q1 | $466K | Sell |
1,396
-254
| -15% | -$84.7K | 0.03% | 239 |
|
2023
Q4 | $447K | Sell |
1,650
-248
| -13% | -$67.1K | 0.04% | 254 |
|
2023
Q3 | $467K | Sell |
1,898
-654
| -26% | -$161K | 0.04% | 229 |
|
2023
Q2 | $774K | Buy |
2,552
+2
| +0.1% | +$607 | 0.06% | 178 |
|
2023
Q1 | $672K | Buy |
2,550
+29
| +1% | +$7.65K | 0.06% | 191 |
|
2022
Q4 | $605K | Sell |
2,521
-30
| -1% | -$7.2K | 0.05% | 209 |
|
2022
Q3 | $469K | Sell |
2,551
-57
| -2% | -$10.5K | 0.05% | 224 |
|
2022
Q2 | $438K | Buy |
2,608
+242
| +10% | +$40.6K | 0.04% | 240 |
|
2022
Q1 | $608K | Hold |
2,366
| – | – | 0.05% | 206 |
|
2021
Q4 | $608K | Buy |
2,366
+62
| +3% | +$15.9K | 0.05% | 206 |
|
2021
Q3 | $559K | Buy |
2,304
+69
| +3% | +$16.7K | 0.05% | 195 |
|
2021
Q2 | $462K | Buy |
2,235
+41
| +2% | +$8.48K | 0.04% | 226 |
|
2021
Q1 | $413K | Buy |
2,194
+30
| +1% | +$5.65K | 0.04% | 229 |
|
2020
Q4 | $356K | Buy |
2,164
+107
| +5% | +$17.6K | 0.04% | 226 |
|
2020
Q3 | $256K | Buy |
+2,057
| New | +$256K | 0.03% | 239 |
|
2020
Q1 | – | Sell |
-1,693
| Closed | -$249K | – | 278 |
|
2019
Q4 | $249K | Buy |
1,693
+30
| +2% | +$4.41K | 0.04% | 243 |
|
2019
Q3 | $200K | Buy |
+1,663
| New | +$200K | 0.04% | 267 |
|